Study examines trends in drug overdose rates with and without opioids

Fatal overdoses involving stimulants (cocaine and other psychostimulants, primarily methamphetamine) have been increasing over the past few years. A recent analysis published in Addiction found that in 2016, 27% of overdose visits to U.S. emergency departments involving cocaine and 14% involving psychostimulants also involved an opioid. Also, in 2017, almost 75% of overdose deaths involving cocaine and half involving psychostimulants involved at least one opioid.

The study also found that since 2006, rates of overdose emergency departments visits involving cocaine and psychostimulants with an opioid increased in recent years, as did those involving psychostimulants without opioids. Overdose deaths involving cocaine and psychostimulants increased in the past several years with and without opioids.

These increases occurred across a broad range of demographic groups and geographic areas, underscoring the escalating nature of the overdose crisis in the United States.

Since opioids are driving increases in some stimulant overdoses, expanding opioid overdose prevention and reversal efforts through risk reduction services and access to medication-assisted treatment is critical for people who use stimulants. Increases in stimulant overdoses without opioids also draws attention to the need for new, evidence-based interventions to address the evolving drug overdose crisis."

Brooke Hoots, PhD, MSPH, lead author, epidemiologist at the Centers for Disease Control and Prevention's National Center for Injury Prevention and Control

Source:
Journal reference:

Hoots, B., et al. (2020) The rise in non‐fatal and fatal overdoses involving stimulants with and without opioids in the United States. Addiction. doi.org/10.1111/add.14878.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Tiny molecule offers hope in reducing opioid side effects